| Epidemiology and risk factors of urothelial bladder cancer | European Urology | 2013 | 1.2K |
| A phase II dose-ranging study of mirabegron in patients with overactive bladder | International Urogynecology Journal | 2013 | 97 |
| A proof-of-concept study: mirabegron, a new therapy for overactive bladder | Neurourology and Urodynamics | 2013 | 70 |
| Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms | European Urology | 2013 | 67 |
| A systematic review of surgical techniques used in the treatment of female urethral stricture | European Urology | 2013 | 65 |
| A prospective patient-centred evaluation of urethroplasty for anterior urethral stricture using a validated patient-reported outcome measure | European Urology | 2013 | 61 |
| The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC) | Urologic Oncology: Seminars and Original Investigations | 2013 | 58 |
| Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours | World Journal of Urology | 2013 | 51 |
| Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis | International Journal of Clinical Practice | 2013 | 48 |
| New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists | Prostate Cancer and Prostatic Diseases | 2013 | 46 |
| Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness? | British Journal of Cancer | 2013 | 43 |
| Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms | European Urology | 2013 | 41 |
| Tissue engineering in urethral reconstruction--an update | Asian Journal of Andrology | 2013 | 39 |
| Degarelix versus goserelin (+ antiandrogen flare protection) in the relief of lower urinary tract symptoms secondary to prostate cancer: results from a phase IIIb study (NCT00831233) | Urologia Internationalis | 2013 | 39 |
| Assessment of endothelial dysfunction by flow-mediated dilatation in men on long-term androgen deprivation therapy for prostate cancer | Experimental Physiology | 2013 | 15 |
| Nocturia: current concepts and future perspectives | Acta Physiologica | 2013 | 12 |
| Overactive bladder syndrome: Current pathophysiological concepts and therapeutic approaches | Arab Journal of Urology Arab Association of Urology | 2013 | 7 |
| Obstructive uropathy secondary to incisional herniation of a transplant ureter - case report and review of literature | Annals of Transplantation | 2013 | 5 |
| Anatomy of the lower urinary tract | Surgery | 2013 | 4 |
| Chronic urinary retention in men: how we define it, and how does it affect treatment outcome | BJU International | 2013 | 4 |
| Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness? | British Journal of Cancer | 2013 | 4 |
| Screening for Prostate Cancer | | 2013 | 2 |
| Transurethral resection biopsy as part of a saturation biopsy protocol: a cohort study and review of the literature | Urologic Oncology: Seminars and Original Investigations | 2013 | 2 |
| Focus on nocturia in the elderly | Aging Health | 2013 | 1 |
| Systematic review of therapy for men with overactive bladder | Canadian Urological Association Journal | 2013 | 1 |
